Related Experiment Video
Updated: Jun 16, 2026

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Macrophage plasticity in experimental atherosclerosis
Jamila Khallou-Laschet1, Aditi Varthaman, Giulia Fornasa
1UMRS698 INSERM, Paris, France.
Abstract:
As in human disease, macrophages (MØ) are central players in the development and progression of experimental atherosclerosis. In this study we have evaluated the phenotype of MØ associated with progression of atherosclerosis in the apolipoprotein E (ApoE) knockout (KO) mouse model.We found that bone marrow-derived MØ submitted to M1 and M2 polarization specifically expressed arginase (Arg) II and Arg I, respectively. This distinct arginase expression was used to evaluate the frequency and distribution of M1 and M2 MØ in cross-sections of atherosclerotic plaques of ApoE KO mice. Early lesions were infiltrated by Arg I(+) (M2) MØ. This type of MØ favored the proliferation of smooth muscle cells, in vitro. Arg II(+) (M1) MØ appeared and prevailed in lesions of aged ApoE KO mice and lesion progression was correlated with the dominance of M1 over the M2 MØ phenotype. In order to address whether the M2->M1 switch could be due to a phenotypic switch of the infiltrated cells, we performed in vitro repolarization experiments. We found that fully polarized MØ retained their plasticity since they could revert their phenotype. The analysis of the distribution of Arg I- and Arg II-expressing MØ also argued against a recent recruitment of M1 MØ in the lesion. The combined data therefore suggest that the M2->M1 switch observed in vivo is due to a conversion of cells already present in the lesion. Our study suggests that interventional tools able to revert the MØ infiltrate towards the M2 phenotype may exert an atheroprotective action.
Insights
Macrophages (MØ) shift from M2 to M1 phenotypes during atherosclerosis progression in ApoE KO mice. This M2 to M1 switch, driven by cell conversion, suggests targeting MØ phenotype could offer atheroprotective benefits.
Area of Science:
- Immunology
- Cardiovascular Research
- Atherosclerosis Pathogenesis
Background:
- Macrophages (MØ) are key players in atherosclerosis development and progression.
- Understanding MØ phenotype dynamics is crucial for therapeutic strategies.
Purpose of the Study:
- To investigate the phenotype of macrophages associated with atherosclerosis progression in apolipoprotein E (ApoE) knockout (KO) mice.
- To determine if MØ phenotype switching occurs in vivo and if it is driven by cell conversion.
Main Methods:
- Utilized bone marrow-derived MØ for in vitro M1/M2 polarization studies.
- Assessed arginase I (Arg I) and arginase II (Arg II) expression to distinguish M1 and M2 MØ phenotypes.
- Analyzed MØ distribution in atherosclerotic plaques of ApoE KO mice.
- Performed in vitro repolarization experiments to assess MØ plasticity.
Main Results:
- M1 MØ expressed Arg II, while M2 MØ expressed Arg I.
- Early lesions contained M2 MØ, which promoted smooth muscle cell proliferation in vitro.
- M1 MØ became dominant in aged ApoE KO mice, correlating with lesion progression.
- In vitro experiments demonstrated MØ plasticity, with the ability to revert phenotypes.
- In vivo data suggested M2 to M1 MØ conversion within existing lesions, rather than new M1 MØ recruitment.
Conclusions:
- The M2 to M1 macrophage phenotype switch in atherosclerosis is likely due to conversion of resident cells, not solely recruitment.
- Targeting MØ phenotype to promote an M2 phenotype may represent a viable atheroprotective strategy.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Chronic Inflammation: Introduction
Coronary Artery Disease II: Pathophysiology